NCT00290251 2024-07-15
Treatment of Uterine Fibroids With the Selective Progesterone Receptor Modulator CDB-2914
National Institutes of Health Clinical Center (CC)
Phase 2 Completed
Clinical Trials
9 trialsNCT02408770 2023-05-06
BC-APPS1
Manchester University NHS Foundation Trust
Phase 2 Completed
NCT02922127 2020-02-07
Compare Daily Ulipristal Acetate and Combined Oral Contraceptive Effects on Breast Epithelial Cell Proliferation
Columbia University
Phase 1 Completed
NCT01629563 2019-09-04
PEARLIV
PregLem SA
Phase 3 Completed
NCT02147158 2019-06-04
A Study of the Efficacy and Safety of Ulipristal Acetate Intermittent Treatment for Abnormal Uterine Bleeding Associated With Leiomyomas
Allergan
Phase 3 Completed
NCT02147197 2019-04-30
A Study of the Efficacy and Safety of a 3-month Treatment Course of Ulipristal Acetate for the Treatment of Abnormal Uterine Bleeding Associated With Leiomyomas
Allergan
Phase 3 Completed
NCT03349190 2019-01-09
NACRE
ASSOCIATION POUR LE DEVELOPPEMENT EN FECONDATION IN VITRO
Completed
NCT01156857 2016-01-15
PEARLIII
PregLem SA
Phase 3 Completed
NCT01252069 2016-01-13
PGL4001 Efficacy Assessment in Reduction of Symptoms Due to Uterine Leiomyomata (PEARLIII-extension Study)
PregLem SA
Phase 3 Completed